Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Acute tubular injury
Diffuse glomerulosclerosis
Myeloproliferative neoplasm
Nephropathology
Journal
Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
24
03
2021
accepted:
27
05
2021
revised:
17
05
2021
pubmed:
25
6
2021
medline:
23
11
2021
entrez:
24
6
2021
Statut:
ppublish
Résumé
Myeloproliferative neoplasms (MPN) are a heterogeneous group of hematological disorders presenting with an increased proliferation in one or several hematological cell lines. Renal manifestations of MPN have not been fully characterized so far. To morphologically assess the potential renal involvement in MPN patients, we analyzed histomorphological findings of a post-mortem cohort (n = 57) with a disease history of Philadelphia-negative MPN including polycythaemia vera, primary myelofibrosis, essential thrombocythemia, or chronic myelomonocytic leukemia (CMML). Seven (12.2%) patients presented with a pattern of diffuse glomerulosclerosis not attributable to diabetic or hypertensive nephropathy. Weak C4d staining suggestive for chronic thrombotic microangiopathy (TMA) was observed in 4/7 cases. Glomerulonephritis was excluded by light microscopy and immunohistochemistry. Patients with a pattern of diffuse glomerulosclerosis did not differ from the rest of the cohort regarding MPN subtype, disease duration, age, or sex. No significant proteinuria had been observed before death. Further findings attributed to MPNs were extramedullary hematopoiesis (n = 5; 8.8%) and tumor involvement in advanced disease (n = 4; 7.0%). Other common findings included arteriolosclerosis (n = 18; 31.6%) and signs of shock (n = 8; 14.0%). To our knowledge, this study is so far the largest investigating renal findings in MPN patients. There may be a causal relationship between idiopathic diffuse glomerular sclerosis and MPN, although its clinical significance and pathophysiology remain uncertain with TMA probably being relevant in a subgroup of cases. Our findings demonstrate the spectrum of renal findings in MPN from early to terminal disease of which hematologists should be aware of in daily clinical practice.
Identifiants
pubmed: 34164707
doi: 10.1007/s00428-021-03129-y
pii: 10.1007/s00428-021-03129-y
pmc: PMC8572822
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1013-1020Informations de copyright
© 2021. The Author(s).
Références
Am J Hematol. 2019 Jan;94(1):133-143
pubmed: 30281843
Kidney Int Rep. 2019 Jul 30;4(11):1555-1567
pubmed: 31890997
Ann Intern Med. 1962 Jul;57:73-84
pubmed: 14038381
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
Blood Rev. 2020 Jul;42:100711
pubmed: 32505517
Ann Hematol. 2020 Dec;99(12):2779-2785
pubmed: 32862283
Kidney Int. 2011 Oct;80(7):753-9
pubmed: 21654720
Am J Kidney Dis. 1998 Apr;31(4):559-73
pubmed: 9531171
N Engl J Med. 2017 Jun 1;376(22):2168-2181
pubmed: 28564565
Biol Blood Marrow Transplant. 2018 Mar;24(3):571-580
pubmed: 29155318
Ann Intern Med. 2013 Jun 4;158(11):825-30
pubmed: 23732715
Mod Pathol. 2015 Dec;28(12):1574-83
pubmed: 26449764